RS Research is a clinical-stage biotechnology start-up discovering and developing smart nanomedicines, based on innovative drug delivery platform Sagitta® for targeted chemotherapy. Bringing together the powers of science and industry, we have developed a pipeline that will help patients fight cancer with a superior therapeutic index, “a Cure With a Smile”.
Looking for a particular RS Research employee's phone or email?
The RS Research annual revenue was $23.5 million in 2026.
Rana Sanyal is the Co-Founder and CSO of RS Research.
14 people are employed at RS Research.
RS Research is based in Istanbul, Istanbul.
The NAICS codes for RS Research are [54, 541714, 5417, 54171, 541].
The SIC codes for RS Research are [87, 873].